Idiopathic pulmonary fibrosis
RecruitingPhase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
- Disease:Idiopathic pulmonary fibrosis
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Germany635 clinical trials in Hanover, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on respiratory infections and conditions, including studies of vaccines against RSV and human metapneumovirus in older adults. Research also includes treatment evaluation for chronic obstructive pulmonary disease.
Multiple studies are evaluating novel therapeutic approaches for both acute and chronic respiratory conditions.
Innovative trials in cancer treatment, including studies for bladder cancer, multiple myeloma, and advanced breast cancer. Research focuses on combination therapies and novel treatment approaches.
Studies emphasize personalized treatment approaches and immune system-based therapies.
Research focusing on neurodegenerative diseases, particularly Alzheimer's Disease and Amyotrophic Lateral Sclerosis. Studies evaluate new diagnostic tools and therapeutic interventions.
Trials aim to address both symptomatic treatment and disease progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.